Our Team
Steven Squinto
BOARD MEMBER
Dr Stephen Squinto is a board member at Averna Therapeutics and a biotechnology industry veteran with over 30 years of drug development experience. He currently serves as Chief Investment Officer and managing partner of J.P. Morgan Life Sciences Private Capital. His distinguished career includes serving as an executive partner at OrbiMed Advisors and interim CEO at Passage Bio. He cofounded Alexion Pharmaceuticals, where he served as Executive Vice President and Chief Global Operations Officer, held various positions at Regeneron Pharmaceuticals, and held joint academic appointments at Tulane University and LSU Medical Schools.
He received his BA and PhD from Loyola University of Chicago and is the recipient of numerous honors and awards.